PatrickJosephStiffMD

Oncology • Maywood, IL

Professor of Hematology & Oncology, Loyola University-Stritch School of Medicine

Join to view full profile

Dr. Stiff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stiff's full profile

Already have an account?

Office
2160 S 1st Ave
# Luh-Nort
Maywood, IL 60153
Phone+1 708-216-3304

Fax+1 708-216-1259

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1978 - 1981
Cleveland Clinic FoundationResidency, Internal Medicine, 1975 - 1978
Loyola University Chicago Stritch School of MedicineClass of 1975

Certifications & Licensure

IL State Medical License 1981 - 2026
IN State Medical License 2013 - 2025
OH State Medical License 1976 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top Doctors Castle-Connolly, 2013-2019
West Suburban Living Magazine Castle Connolly, 2014
America's Top Doctors Castle Connolly, 2002-2014
Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer Start of enrollment: 1991 Feb 01
Completed
Phase 2
Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer Start of enrollment: 1996 Nov 01
Terminated
Phase 3
SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Start of enrollment: 1997 Jul 01
Completed
Phase 3
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma Start of enrollment: 2005 Jul 01
Terminated
Phase 2
S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma Start of enrollment: 2005 Oct 01
Completed
Phase 2
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy Start of enrollment: 2007 Oct 01
Completed
Phase 2, Phase 3
Adult Double Cord Blood Transplant Study Start of enrollment: 2007 Aug 01
Completed
Phase 2
Ovarian Dendritic Cell Vaccine Trial Start of enrollment: 2008 Oct 01
Recruiting
Phase 2
Odansetron and Dexamethasone Alone vs. Odansetron, Dexamethason and Apreptant to Prevent Nausea Start of enrollment: 2003 Aug 01
Completed
Phase 4
Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma Start of enrollment: 2009 Jan 01
Terminated
Phase 2
Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies Start of enrollment: 2010 Nov 01
Completed
Phase 1, Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Roles: Principal Investigator, Contact
Umbilical Cord Transplantation for the Elderly Population Start of enrollment: 2010 Jan 01
Completed
Phase 2
The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies. Start of enrollment: 2012 Jul 01
Terminated
Phase 2
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS Start of enrollment: 2012 Jan 01
Recruiting
Phase 2
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Start of enrollment: 2014 May 01
Terminated
Phase 3
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) Start of enrollment: 2014 Aug 01
Completed
Phase 2
Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL Start of enrollment: 2006 Jun 01
Completed
Not Applicable
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT Start of enrollment: 2019 Dec 10
Withdrawn
Phase 3
Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant Start of enrollment: 2020 Oct 29
Completed
Phase 3
Busulfan, Melphalan, Escalating Carfilzomib Conditioning Auto Stem Cell Transplantation for Multiple Myeloma (MM) Start of enrollment: 2019 May 22
Recruiting
Phase 1, Phase 2
Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL) Start of enrollment: 2020 Nov 18
Suspended
Phase 1, Phase 2
A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) Start of enrollment: 2022 Jun 16
Terminated
Phase 3
Roles: Contact
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer Start of enrollment: 2023 Nov 16
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Randomized Phase III SIERRA Trial ofI-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.
Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah Choe, Mark R Litzow
Journal of Clinical Oncology. 2024-09-19
Busulfan, melphalan and carfilzomib high-dose chemotherapy and autologous haematopoietic stem cell transplantation in multiple myeloma.
Patrick Hagen, Joseph Norton, Stephanie Tsai, Loredana Campo, Mary Lee
British Journal of Haematology. 2024-04-01
2 citations
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids.
Olalekan O Oluwole, Edouard Forcade, Javier Muñoz, Sophie de Guibert, Julie M Vose
Bone Marrow Transplantation. 2024-03-01

Journal Articles

Five-Year PFS from the AETHERA Trial of Brentuximab Vedotin for Hodgkin Lymphoma at High Risk of Progression or Relapse
Patrick Stiff, Edward Agura, Craig H Moskowitz, John Sweetenham, Auayporn Nademanee, Veronika Bachanova, Blood

Abstracts/Posters

A Phase 2, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Axicabtagene Ciloleucel in Combination with Either Rituximab or Lenalidomide in Patients...
Patrick J. Stiff, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
A Phase 1 Study of ACTR087 in Combination with Rituximab, in Subjects with Relapsed or Refractory CD20-Positive B-Cell Lymphoma
Patrick J. Stiff, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Mu...
Patrick J. Stiff, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Fractionated Dosing of CLR 131 in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
Patrick J. Stiff, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all

Press Mentions

Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer DoctorsNovember 6th, 2019
Cancer Survivor Reunited with Life-Saving Donor After Their DNA Matches on Ancestry.comSeptember 9th, 2019
Chance DNA Test Connects Cancer Patient to Donor Who Saved Her LifeSeptember 9th, 2019
Join now to see all

Committees

Chair, SWOG Blood and Marrow Transplant Committee 2013 - Present